References
- 1. World Health Organization. Mental and neurological disorders. Geneva: World Health Organization. [Online].; 2006 [cited 2017 October 19. Available from: http://www.who.int/whr/2001/media_centre/en/whr01_fact_sheet1_en.pdf.
- 2. O’Donnell JM, Shelton RC. Drug Therapy of Depression and Anxiety Disorders [In: Brunton LL, Chabner BA, Knollmann BC. eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 12e New York, NY: McGraw-Hill;].: Times by Glyph International. Available from: http://accessmedicine.mhmedical.com/content.aspx?bookid=1613§ionid=102158640. Accessed February 16, 2018.
- 3. Kessler RC, Chiu WT, Demler O. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication http. Arch Gen Psychiat. 2005; 62(6):617-27.
- 4. Hindmarch I. Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol. 2001; 16(3):203-18.
- 5. Antonijevic IA. Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinol. 2006; 31(1):1-15.
- 6. Sarris J, Kavanagh D. Kava and St. John’s wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med. 2009; 15(8):827-36.
- 7. Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most important medicinal plants on two important psychiatric disorders (anxiety and depression) a review. Asian Pac J Trop Med. 2014; 7(1):34-42.
- 8. Du H, Wu J, Li H et al. Polyphenols and triterpenes from Chaenomeles fruits: Chemical analysis and antioxidant activities assessment. Food Chem. 2013; 141(4):4260-8.
- 9. Елисеева ЛГ, Блинникова ОМ, Пехташева ЕЛ. Оценка потребительских свойств плодов хеномелеса Маулея. Товаровед продовольственных товаров. 2012; 6:4-7.
- 10. Youdim KA, Qaiser MZ, Begley DJ et al. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 2004; 36(5):592-604.
- 11. El Mohsen MA, Marks J, Kuhnle G et al. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr. 2006; 95(1): 51-8.
- 12. Scholey AB, French SJ, Morris PJ et al. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psycho-pharmacol. 2010; 24(10):1505-14.
- 13. Oliveira DR, Sanada PF, Saragossa Filho AC et al. Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence. Brain Res. 2009; 1269:68-89.
- 14. Eftimov M, Valcheva-Kuzmanova S. Antidepressant-like effect of Aronia melanocarpa fruit juice applied subchronically to rats. Scripta Scientifica Medica. 2013; 45(6):7-11.
- 15. Oyama Y, Chikahisa L, Ueha T et al. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 1996; 712(2):349-52.
- 16. Blecharz-Klin K, Piechal A, Joniec I et al. Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiol Exp. 2009; 69:217-31.
- 17. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. Am J Enol Viticult. 1965; 16:144-58.
- 18. Valcheva-Kuzmanova S, Zhelyazkova-Savova M. Anxiolytic-like effect of Aronia melanocrpa fruit juice in rats. Methods Find Exp Clin Pharmacol. 2009; 31(10):651-4.
- 19. File SE, Hyde JR. Can social interaction be used to measure anxiety. Br J Pharmacol. 1978; 62:19-24.
- 20. Irvine EE, Bagnalasta M, Marcon C et al. Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacol. 2001; 153:315-20.
- 21. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977; 266:730-2.
- 22. Castagne V, Moser P, Porsolt RD. Chapter 6 Behavioral Assessment of Antidepressant Activity in Rodents. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Available from: https://www.ncbi.nlm.nih.gov/books/NBK5227/.
- 23. File SE. The validation of animal tests of anxiety-pharmacological implications. Pol J pharmacol Pharm. 1984; 36: p. 505-12.
- 24. Rex A, Voigt J, Gustedt C et al. Anxiolytic-like profile in Wistar, but not Sprague–Dawley rats in the social interaction test. Psychopharmacol. 2004; 177:23-34.
- 25. Slattery DA, Cryan J. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nature Protocol. 2012; 7(6):1009-14.
- 26. Yankelevitch-Yahav R, Franko M, Huly A et al. The Forced Swim Test as a Model of Depressive-like Behavior. J Vis Exp. 2015; 97:525-87.
- 27. Liu Y, Jia G, Gou L et al. Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress. Pharm Biochem Behav. 2013; 104:27-32.
- 28. Bouayed J. Polyphenols: A Potential New Strategy for the Prevention and Treatment of Anxiety and Depression. Curr Nutr Food Sci. 2010; 6(1):13-8.
- 29. Jia M, Li C, Zheng Y et al. Leonurine Exerts Antidepressant-Like Effects in the Chronic Mild Stress-Induced Depression Model in Mice by Inhibiting Neuroinflammation. Int J Neuropsychopharmacol. 2017;(https://doi.org/10.1093/ijnp/pyx062):1-10.10.1093/ijnp/pyx062):1-10
- 30. Zhao G, Jiang Z, Zheng X. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol Biochem Behav. 2008; 90:363-71.
- 31. Mori T, Rezai-Zadeh K, Koyama N et al. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem. 2012; 287(9):6912-27.
- 32. Gospodinova Z, Bózsity N, Nikolova M et al. Antiproliferative Properties Against Human Breast, Cervical and Ovarian Cancer Cell Lines, and Antioxidant Capacity of Leaf Aqueous Ethanolic Extract from Cotinus coggygria Scop. Acta Medica Bulgarica. 2017; 44(2):20-5.